A Phase I Dose Escalating Study of the Safety and Tolerability of Gadolinium Texaphyrin [motexafin gadolinium] as a Radiation Sensitizer in Patients With Primary Glioblastoma Multiforme

Trial Profile

A Phase I Dose Escalating Study of the Safety and Tolerability of Gadolinium Texaphyrin [motexafin gadolinium] as a Radiation Sensitizer in Patients With Primary Glioblastoma Multiforme

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2007

At a glance

  • Drugs Motexafin gadolinium (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jul 2007 Status changed from in progress to completed.
    • 02 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top